LY-293558, a new glutamate receptor antagonist, evaluated for safety and analgesic efficacy March 21, 2000
TxA2 antagonist from Bayer may have potential in atherosclerosis according to ACC presentation March 20, 2000
Cariporide: no improvement in myocardial stunning/infarct size in GUARDIAN trial subgroup March 20, 2000
Impressive evidence for antiatherosclerotic efficacy of VasoCare therapy presented at ACC March 17, 2000
RSS